Dual oral iron chelation in children with transfusion dependent beta thalassemia real world efficacy data

Dual oral iron chelation in children with transfusion dependent beta thalassemia real world efficacy data

Bibliographic Details
Main Authors:	Amitoj Singh Chadha, Abaan Ul Haq Khazi Mohammed, Namratha S. Naik, Kenson Sam Alex, Anand Prakash
Format:	Article
Language:	English
Published:	Elsevier 2022-01-01
Series:	Pediatric Hematology Oncology Journal
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468124522002923

Similar Items

Iron Chelator Drugs in Transfusion Dependent Thalassemia: a Review
by: M Hashemieh
Published: (2020-08-01)

Iron chelation monotherapy in transfusion-dependent beta-thalassemia major patients: a comparative study of deferasirox and deferoxamine
by: Mohamed Abdel Malik Hassan, et al.
Published: (2016-05-01)

Ocular abnormalities in patients with beta thalassemia on transfusion and chelation therapy: Our experience
by: Jethani Jitendra, et al.
Published: (2010-01-01)

Barriers to adherence to iron chelation therapy among adolescent with transfusion dependent thalassemia
by: Rafaa Mohamed, et al.
Published: (2022-10-01)

Promoting Adherence to Iron Chelation Treatment in Beta-Thalassemia Patients
by: Eziefula C, et al.
Published: (2022-06-01)

Iron chelation therapy in transfusion-dependent thalassemia patients: current strategies and future directions
by: Saliba AN, et al.
Published: (2015-06-01)

Brazilian Thalassemia Association protocol for iron chelation therapy in patients under regular transfusion
by: Monica Pinheiro de Almeida Verissimo, et al.
Published: (2013-01-01)

Relationship between the amount of blood transfusion and the amount of iron chelation with blood and salivary ureum levels in children with beta thalassemia major
by: Pradypta, Putu Gyzca, et al.

Safety and Efficacy of the New Combination Iron Chelation Regimens in Patients with Transfusion-Dependent Thalassemia and Severe Iron Overload
by: Raffaella Origa, et al.
Published: (2022-04-01)

Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia
by: Murtadha Al-Khabori, et al.
Published: (2013-03-01)

The Non-adherence to iron chelation therapy (ICT) among transfusion-dependent thalassemia (TDT) patients in Pakistan
by: Fariha Arif, et al.
Published: (2023-08-01)

Zinc and copper in transfusion-dependent thalassemia patients on different iron chelators in Basrah: A case-control study
by: Balqees Kadhim Hasan, et al.
Published: (2023-01-01)

A Review of Iron Overload in Beta-Thalassemia Major, and a Discussion on Alternative Potent Iron Chelation Targets
by: Piyush Kumar Yadav, et al.
Published: (2022-05-01)

Melanin nanoparticles as a potential iron chelation therapy for women with beta thalassemia during pregnancy
by: Bakhamis, N
Published: (2022)

Side effect of deferiprone as iron chelator in patient with thalassemia
by: Mikhael Yosia, et al.
Published: (2018-01-01)

Iron Chelation Therapy in Sickle Cell/Beta Thalassemia Syndrome, a 2 years’ Extension Study
by: Hayder Al-Momen
Published: (2019-04-01)

Iron overload in non-transfusion-dependent thalassemia
by: Khaled M. Musallam
Published: (2013-03-01)

Anthropometry in Children with Transfusion-Dependent Beta-Thalassemia Major
by: Noor Un Nisa, et al.
Published: (2023-12-01)

Ocular abnormalities in multi-transfused beta-thalassemia patients
by: Reza Jafari, et al.
Published: (2015-01-01)

Transfusion-induced hemoglobinopathy in patients of beta-thalassemia major
by: Sanjeev K Gupta, et al.
Published: (2011-01-01)

Effects of Vitamin E on Transfusion Requirements in TransfusionDependent Beta-Thalassemia Patients
by: Duangdee Trangsuwan, et al.
Published: (2018-08-01)

Mutational analysis of thalassemia in transfusion-dependent beta-thalassemia patients from central India
by: Manisha Shrivastava, et al.
Published: (2019-01-01)

Thalassemia Intermedia: Chelator or Not?
by: Yen-Chien Lee, et al.
Published: (2022-09-01)

Urinary hepcidin levels in children with beta-thalassemia major on chelation therapy
by: Kritika Goel, et al.
Published: (2022-01-01)

Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review
by: Romadhon, Pradana Zaky, et al.
Published: (2022)

Markers of Renal Complications in Beta Thalassemia Patients with Iron Overload Receiving Chelation Agent Therapy: A Systematic Review
by: Romadhon PZ, et al.
Published: (2022-11-01)

Predictors of Non-adherence to iron chelation therapy in pediatric thalassemia patients
by: Muniba Kanwal, et al.
Published: (2022-06-01)

The Correlation Between Iron Overload and Endocrine Function in Adult Transfusion-Dependent Beta-Thalassemia Patients with Growth Retardation
by: Atmakusuma TD, et al.
Published: (2021-08-01)

Correlation of Serum Ferritin and Cardiac Iron Toxicity with Cardiac Function in Transfusion Dependent Beta-Thalassemia Major Patients
by: Tubagus Djumhana Atmakusuma, et al.
Published: (2021-07-01)

Understanding Iron Metabolism: Lessons from Transfusion-dependent Thalassemia
by: Murtadha Al-Khabori, et al.
Published: (2018-01-01)

Knowledge, Attitude, and Practice of Young Paediatricians About Chelation Therapyin Transfusion-Dependent Thalassemia Major Children
by: Misbah Fakih, et al.
Published: (2022-12-01)

Molecular basis of transfusion dependent beta-thalassemia major patients in Sabah
by: Teh, Lai Kuan, et al.
Published: (2014)

GDF‐15 is associated with atherosclerosis in adults with transfusion‐dependent beta‐thalassemia
by: Alaa Efat, et al.
Published: (2022-05-01)

Hepatitis B seroconversion amongst patients with transfusion-dependent beta thalassemia
by: Nirali Sanghvi, et al.
Published: (2022-01-01)

Post‐transfusion hyperhemolysis syndrome in a patient with beta thalassemia major
by: Ganesh Kasinathan, et al.
Published: (2021-06-01)

Assessment of iron chelation therapy adherence in patients with thalassemia major in Babylon Province
by: Mohammed Ali Al-Jabory, et al.
Published: (2023-01-01)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Ebrahim miri moghaddam, et al.
Published: (2011-04-01)

The Best Iron Chelation Therapy in Major Thalassemia Patients is Combination of Desferrioxamine and Deferiprone
by: Mohammad Ali Mashhadi, et al.
Published: (2011-06-01)

Renal Function in Children with β-Thalassemia Major Treated with Iron Chelating Agent
by: Olga Rasiyanti Siregar, et al.
Published: (2020-09-01)

Iron chelating properties of Eltrombopag: Investigating its role in thalassemia-induced osteoporosis.
by: Francesca Punzo, et al.
Published: (2018-01-01)